SCHEMBL4300988

SCHEMBL4300988

C1=CC1.NC(=O)c1ccc(O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 4/20 0.63
CA2 P00918 4/20 0.50
CA1 P00915 3/20 0.50
MAPT P10636 2/20 0.50
ESR1 P03372 2/20 0.50
ESR2 Q92731 2/20 0.50
LMNA P02545 2/20 0.50
PKM P14618 1/20 0.50
HPGD P15428 1/20 0.50
HTT P42858 1/20 0.50
PARP4 Q9UKK3 2/20 0.48
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.48
PARP15 Q460N3 1/20 0.48
PARP14 Q460N5 1/20 0.48
PARP16 Q8N5Y8 1/20 0.48
PARP11 Q9NR21 1/20 0.48
PARP1 P09874 3/20 0.48
CYP3A4 P08684 2/20 0.48
BLM P54132 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroquinone SCHEMBL8674228 0.90 PARP10 (0.74) PARP10CA2CA1MAPTESR1
SCHEMBL28823636 0.90 PARP10 (0.74) PARP10CA2CA1MAPTESR1
SCHEMBL162830 0.90 PARP10 (0.74) PARP10CA2CA1MAPTESR1
SCHEMBL25338154 0.88 PARP10 (0.65) PARP10CA2CA1MAPTESR1
SCHEMBL28831945 0.87 PARP10 (0.71) PARP10CA2CA1MAPTESR1
Ammonia Solution, Strong SCHEMBL28805645 0.87 PARP10 (0.71) PARP10CA2CA1MAPTESR1
Methane SCHEMBL28048015 0.87 PARP10 (0.71) PARP10CA2CA1MAPTESR1
Hydrochloric Acid SCHEMBL3139339 0.87 PARP10 (0.71) PARP10CA2CA1MAPTESR1
SCHEMBL1791123 0.83 PARP10 (0.65) PARP10CA2CA1MAPTESR1
Benzamide SCHEMBL10890603 0.81 MAPT (0.76) PARP10CA2CA1MAPTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2073803-A1 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-07-01 EP disclosed
WO-2008044041-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 WO disclosed